French chemicals firm, Rhodia (BBB-, stable/Baa3, negative) is still a name listed on the new issue pipeline, but it seems the market may be waiting in vain for the borrower to launch its planned €300-€500 million deal.

Lead managers BNP Paribas, HSBC and Fortis say the deal has been postponed and they are unable to provide any new information, blaming the high-yield premium demanded by investors for the postponement. But some wonder whether the deal will actually surface at all.

Says Mu

To continue reading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: